Léro Eucalyptol
Food supplement declared in France, declaration No 2018-6-65, decision dated 4 June 2018
Léro Eucalyptol (Laboratoire Léro) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- Laboratoire Léro
- Food business operator placing the product on the market
- DOMES PHARMA FR
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Capsule
- Daily dose
- 3
- Directions for use
- 1 capsule matin, midi et soir
- Intended populations
- Adolescents de 11 à 17 ans, Personnes de plus de 60 ans, Homme, Femme
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes
- Objectives stated by the manufacturer (these are not authorised claims)
- Voies respiratoires
Declaration 269069, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Eucalyptus globulus Labill. | Essence (parties aériennes) | Distillation | 129 mg |
| Lavandula angustifolia Mill. | Essence (sommités fleuries) | Distillation | 80 mg |
| Myrtus communis L. | Essence (feuille) | Distillation | 44 mg |
Additives
E422, E407, E339, E1440
Other ingredients
huile de colza
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging
Label warnings
Contre-indiqué en cas d'épilepsie, d'inflammation gastro-digestive et des voies biliaires et de maladie hépatique sévère.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Léro Eucalyptol Léro, declared in 2023 : different composition: 1 ingredient(s) added, 4 missing
Brand : Laboratoire Léro